Passage Bio

1 follower

‌

Passage Bio is a genetic medicines company based in Philadelphia, PA that is developing a deep pipeline of adeno-associated virus (AAV) delivered therapeutics for the treatment of rare monogenic central nervous system disorders (CNS).

Industries

Biotechnology

Headquarters

Philadelphia, United States

Employees

51-200

Links

Org chart

William Chou

President & CEO

William Chou

Collapse

Mark Forman

Chief Medical Officer

James M. Wilson

Chief Scientific Advisor

Edgar B. Cale

General Counsel & Corporate Secretary

Jiwen Zhang

VP, Regulatory Affairs

Samiah Al-Zaidy

VP, Clinical Development

Kathleen Borthwick

VP, Financial Planning & Analysis

Eden Fucci

VP, Manufacturing Operations

Tiffini Voss

VP, Clinical Development

Stuart Henderson

VP, Corporate Development & Investor Relations

Sue Browne

VP, Biology

Steve Krausert

Vice President, Supply Chain & Planning

Anne Marie Pierce

Finance Operations Specialist

Patricia Elsasser

Director Clinical Operations

Bin Lu

Senior Scientist, Gene Therapy Process And Product Development

Sneh Patel

Senior Scientist

Derek Kichula

Senior Director, Engineering & General Manager

Rich Mastropietro

Executive Director, IT

Rose Johnstone

Executive Director, Data Management

Chelsea Difebbo Ortiz

Executive Director, Patient Advocacy

Glen Kerker II

Director, Regulatory Operations

Teams

+10

Leadership Team

13 members

Scientific Research and Development

12 members

Clinical Operations and Quality Assurance

10 members

Finance and Administrative Support

6 members

Similar companies

Kura Oncology

18 followers

REVOLUTION Medicines

5 followers

Relay Therapeutics

1 follower

Volastra

1 follower

Eikon Therapeutics

1 follower

Scribe Therapeutics

1 follower

Gilead Sciences

128 followers

Regeneron

94 followers

Agilent Technologies

63 followers

Alexion Pharmaceuticals

34 followers

GRAIL

27 followers

Explore companies